Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022

Serotype epidemiology and case-fatality risk of invasive pneumococcal disease: a nationwide population study from Switzerland, 2012–2022

In Switzerland, thirteen-valent pneumococcal conjugate vaccine (PCV13) has been introduced in 2011. During the COVID-19 pandemic, cases of invasive pneumococcal disease (IPD) have decreased but consequences on the serotype epidemiology are less clear. The objective of the study has been to analyse t...

Full description

Saved in:
Bibliographic Details
Main Authors: Werner C. Albrich, Nicolaj Just, Christian Kahlert, Carlo Casanova, Florent Baty, Markus Hilty
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Emerging Microbes and Infections
Subjects:
Invasive pneumococcal disease
incidence
pneumococcal serotypes
PCV-13
COVID-19
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2025.2488189
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items